PT UBC Medical Indonesia Tbk (IDX:LABS)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
152.00
-2.00 (-1.30%)
At close: Mar 27, 2026
Market Cap600.40B +28.8%
Revenue (ttm)176.64B +29.2%
Net Income9.30B +324.8%
EPS2.35 +153.2%
Shares Out3.95B
PE Ratio64.54
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume759,000
Average Volume1,090,735
Open154.00
Previous Close154.00
Day's Range152.00 - 155.00
52-Week Range109.00 - 165.00
Betan/a
RSI55.07
Earnings DateApr 9, 2026

About IDX:LABS

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. The company operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. It offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. The company was founded in 2014 and is based in Jakarta Timur, Jakarta. PT UBC Medical Indonesia Tbk operates as a subsidiary of PT Optel Investama Mulia. [Read more]

Sector Healthcare
Founded 2014
Employees 62
Stock Exchange Indonesia Stock Exchange
Ticker Symbol LABS
Full Company Profile

Financial Performance

In 2024, IDX:LABS's revenue was 147.64 billion, an increase of 8.00% compared to the previous year's 136.70 billion. Earnings were 2.95 billion, an increase of 34.84%.

Financial Statements